“Seven Cancer Patients Receiving Guselkumab for Treatment of Moderate-to-Severe Psoriasis”. Dermatology Reports 14, no. 3 (March 17, 2022). Accessed June 19, 2025. https://journals.pagepress.org/dr/article/view/9282.